Company Profile

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE1886.4060.6 (+3.32 % )
PREV CLOSE (Rs.) 1825.80
OPEN PRICE (Rs.) 1833.20
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 4285
TODAY'S LOW / HIGH (Rs.)1828.05 1923.95
52 WK LOW / HIGH (Rs.)1306.8 2398.55
NSE1891.10 71 (+3.9 % )
PREV CLOSE(Rs.) 1820.10
OPEN PRICE (Rs.) 1820.25
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1891.10 (63 )
VOLUME 33831
TODAY'S LOW / HIGH(Rs.) 1820.25 1924.05
52 WK LOW / HIGH (Rs.)1306.05 2397.7

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.00
TTM EPS (Rs.) 21.78
P/E Ratio 86.63
Book Value (Rs.) 120.32
Face Value (Rs.) 2
MCap (Rs. in Mn) 47160.00
Price/Earning (TTM) 67.99
Price/Sales (TTM) 6.48
Price/Book (MRQ) 15.68
PAT Margin (%) 4.53
ROCE (%) 18.65
Incorporation Year : 1979

Management Info :

Narayan K Seshadri - Chairman Gagan Singh Bedi - Managing Director

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone :

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX
NEWS More
26Apr04-26-2019$ Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliances-Reg. 39 (3) - D
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate in respect of 500 shares as per attached details.
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015,..
03Apr04-03-2019$AstraZeneca Pharma hosts ‘Wellness by the Beach’ Awareness Programme AstraZeneca Pharma hosts ‘

AstraZeneca Pharma India (AZPIL) has hosted an engaging awareness programme, ‘Wellness by the Beach’ at Chennai. The program held at the Besant Nagar beach, the event focussed on spreading awareness about non-communicable diseases like diabetes, cardiovascular disorders and cancer. The event was organised and hosted by the Company employees.

The company is celebrating their 40th anniversary in India, and this event is part of the various activities planned to commemorate the Company's long standing commitment to India.

AstraZeneca Pharma India is a global biopharmaceutical company. The company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The company operates through two segments Healthcare and Clinical Trial.

AstraZeneca Pharma India (AZPIL) has hosted an engaging awarene..
20Mar03-20-2019$ Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliances-Reg. 39 (3) - D
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received for Loss of share certificate and issue of duplicate share certificate in respect of 100 shares as per attached details.
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015,..
31Jan01-31-2019$Astrazeneca Pharma India informs about loss of share certificate Astrazeneca Pharma India inf

Astrazeneca Pharma India has informed about loss of share certificate / issue of duplicate share certificate.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma India has informed about loss of share certi..
18Jan01-18-2019$ICICI Prudential Mutual Fund submits disclosure ICICI Prudential Mutual Fund

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund.

The above information is a part of company’s filings submitted to BSE.

 

The Exchange has received the disclosure under Regulation 29(2)..
Financials More
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit98.24544.41
Gross Profit 84.73 726.64
Operating Profit 123.82875.88
Net Sales 1903.037282.94
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Procter&Gamble Healt (BSE)
 3948.60 (2.48%)
M.Cap ( in Cr)
6554.43
Dr. Reddys Lab (BSE)
 2590.00 (1.54%)
M.Cap ( in Cr)
43021.65
Torrent Pharma (BSE)
 1512.15 (0.97%)
M.Cap ( in Cr)
25586.90
IOL Chem & Pharma (BSE)
 192.05 (3.73%)
M.Cap ( in Cr)
1092.52
Medicamen Biotech (BSE)
 453.15 (1.50%)
M.Cap ( in Cr)
580.78
Shareholding Pattern More
PROMOTERS 75 %
MUTUAL FUNDS/UTI 4.23 %
NON-INSTITUTION 18.68 %
FI/BANKS/INSURANCE 0.03 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested